Global RNA Analysis And Transcriptomics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI06247747

Publication Date:

June 21, 2024

Pages:

101

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global RNA Analysis And Transcriptomics market size was valued at US$ million in 2023. With growing demand in downstream market, the RNA Analysis And Transcriptomics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global RNA Analysis And Transcriptomics market. RNA Analysis And Transcriptomics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNA Analysis And Transcriptomics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNA Analysis And Transcriptomics market.
Transcriptomics and RNA analysis refers to the study of the transcriptome or the complete set of RNA transcripts which are produced by the genome under specific circumstances or in a specific cell.
Key Features:
The report on RNA Analysis And Transcriptomics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the RNA Analysis And Transcriptomics market. It may include historical data, market segmentation by Type (e.g., Microarrays, Polymerase Chain Reaction), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNA Analysis And Transcriptomics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the RNA Analysis And Transcriptomics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the RNA Analysis And Transcriptomics industry. This include advancements in RNA Analysis And Transcriptomics technology, RNA Analysis And Transcriptomics new entrants, RNA Analysis And Transcriptomics new investment, and other innovations that are shaping the future of RNA Analysis And Transcriptomics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNA Analysis And Transcriptomics market. It includes factors influencing customer ' purchasing decisions, preferences for RNA Analysis And Transcriptomics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNA Analysis And Transcriptomics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNA Analysis And Transcriptomics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNA Analysis And Transcriptomics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNA Analysis And Transcriptomics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNA Analysis And Transcriptomics market.
Market Segmentation:
RNA Analysis And Transcriptomics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Microarrays
Polymerase Chain Reaction
Sequencing Technologies
RNAI Gene Silencing
Segmentation by application
Academic Research Institutes
Pharmaceutical Companies
Hospitals and Diagnostic Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Affymetrix Inc.(Thermo Fisher Scientific)
Agilent Technologies, Inc.
Bio-Rad Laboratories
GE Healthcare Systems(GE)
Illumina, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Sigma-Aldrich(Merck KGaA)
Fluidigm Corporation
Danaher Corporation
Acobiom
Lexogen GmbH
Promega Corporation

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Analysis And Transcriptomics Market Size 2019-2030
2.1.2 RNA Analysis And Transcriptomics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 RNA Analysis And Transcriptomics Segment by Type
2.2.1 Microarrays
2.2.2 Polymerase Chain Reaction
2.2.3 Sequencing Technologies
2.2.4 RNAI Gene Silencing
2.3 RNA Analysis And Transcriptomics Market Size by Type
2.3.1 RNA Analysis And Transcriptomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global RNA Analysis And Transcriptomics Market Size Market Share by Type (2019-2024)
2.4 RNA Analysis And Transcriptomics Segment by Application
2.4.1 Academic Research Institutes
2.4.2 Pharmaceutical Companies
2.4.3 Hospitals and Diagnostic Centers
2.5 RNA Analysis And Transcriptomics Market Size by Application
2.5.1 RNA Analysis And Transcriptomics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global RNA Analysis And Transcriptomics Market Size Market Share by Application (2019-2024)
3 RNA Analysis And Transcriptomics Market Size by Player
3.1 RNA Analysis And Transcriptomics Market Size Market Share by Players
3.1.1 Global RNA Analysis And Transcriptomics Revenue by Players (2019-2024)
3.1.2 Global RNA Analysis And Transcriptomics Revenue Market Share by Players (2019-2024)
3.2 Global RNA Analysis And Transcriptomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA Analysis And Transcriptomics by Regions
4.1 RNA Analysis And Transcriptomics Market Size by Regions (2019-2024)
4.2 Americas RNA Analysis And Transcriptomics Market Size Growth (2019-2024)
4.3 APAC RNA Analysis And Transcriptomics Market Size Growth (2019-2024)
4.4 Europe RNA Analysis And Transcriptomics Market Size Growth (2019-2024)
4.5 Middle East & Africa RNA Analysis And Transcriptomics Market Size Growth (2019-2024)
5 Americas
5.1 Americas RNA Analysis And Transcriptomics Market Size by Country (2019-2024)
5.2 Americas RNA Analysis And Transcriptomics Market Size by Type (2019-2024)
5.3 Americas RNA Analysis And Transcriptomics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Analysis And Transcriptomics Market Size by Region (2019-2024)
6.2 APAC RNA Analysis And Transcriptomics Market Size by Type (2019-2024)
6.3 APAC RNA Analysis And Transcriptomics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA Analysis And Transcriptomics by Country (2019-2024)
7.2 Europe RNA Analysis And Transcriptomics Market Size by Type (2019-2024)
7.3 Europe RNA Analysis And Transcriptomics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Analysis And Transcriptomics by Region (2019-2024)
8.2 Middle East & Africa RNA Analysis And Transcriptomics Market Size by Type (2019-2024)
8.3 Middle East & Africa RNA Analysis And Transcriptomics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA Analysis And Transcriptomics Market Forecast
10.1 Global RNA Analysis And Transcriptomics Forecast by Regions (2025-2030)
10.1.1 Global RNA Analysis And Transcriptomics Forecast by Regions (2025-2030)
10.1.2 Americas RNA Analysis And Transcriptomics Forecast
10.1.3 APAC RNA Analysis And Transcriptomics Forecast
10.1.4 Europe RNA Analysis And Transcriptomics Forecast
10.1.5 Middle East & Africa RNA Analysis And Transcriptomics Forecast
10.2 Americas RNA Analysis And Transcriptomics Forecast by Country (2025-2030)
10.2.1 United States RNA Analysis And Transcriptomics Market Forecast
10.2.2 Canada RNA Analysis And Transcriptomics Market Forecast
10.2.3 Mexico RNA Analysis And Transcriptomics Market Forecast
10.2.4 Brazil RNA Analysis And Transcriptomics Market Forecast
10.3 APAC RNA Analysis And Transcriptomics Forecast by Region (2025-2030)
10.3.1 China RNA Analysis And Transcriptomics Market Forecast
10.3.2 Japan RNA Analysis And Transcriptomics Market Forecast
10.3.3 Korea RNA Analysis And Transcriptomics Market Forecast
10.3.4 Southeast Asia RNA Analysis And Transcriptomics Market Forecast
10.3.5 India RNA Analysis And Transcriptomics Market Forecast
10.3.6 Australia RNA Analysis And Transcriptomics Market Forecast
10.4 Europe RNA Analysis And Transcriptomics Forecast by Country (2025-2030)
10.4.1 Germany RNA Analysis And Transcriptomics Market Forecast
10.4.2 France RNA Analysis And Transcriptomics Market Forecast
10.4.3 UK RNA Analysis And Transcriptomics Market Forecast
10.4.4 Italy RNA Analysis And Transcriptomics Market Forecast
10.4.5 Russia RNA Analysis And Transcriptomics Market Forecast
10.5 Middle East & Africa RNA Analysis And Transcriptomics Forecast by Region (2025-2030)
10.5.1 Egypt RNA Analysis And Transcriptomics Market Forecast
10.5.2 South Africa RNA Analysis And Transcriptomics Market Forecast
10.5.3 Israel RNA Analysis And Transcriptomics Market Forecast
10.5.4 Turkey RNA Analysis And Transcriptomics Market Forecast
10.5.5 GCC Countries RNA Analysis And Transcriptomics Market Forecast
10.6 Global RNA Analysis And Transcriptomics Forecast by Type (2025-2030)
10.7 Global RNA Analysis And Transcriptomics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Affymetrix Inc.(Thermo Fisher Scientific)
11.1.1 Affymetrix Inc.(Thermo Fisher Scientific) Company Information
11.1.2 Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Product Offered
11.1.3 Affymetrix Inc.(Thermo Fisher Scientific) RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Affymetrix Inc.(Thermo Fisher Scientific) Main Business Overview
11.1.5 Affymetrix Inc.(Thermo Fisher Scientific) Latest Developments
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Information
11.2.2 Agilent Technologies, Inc. RNA Analysis And Transcriptomics Product Offered
11.2.3 Agilent Technologies, Inc. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agilent Technologies, Inc. Main Business Overview
11.2.5 Agilent Technologies, Inc. Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories RNA Analysis And Transcriptomics Product Offered
11.3.3 Bio-Rad Laboratories RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 GE Healthcare Systems(GE)
11.4.1 GE Healthcare Systems(GE) Company Information
11.4.2 GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Product Offered
11.4.3 GE Healthcare Systems(GE) RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GE Healthcare Systems(GE) Main Business Overview
11.4.5 GE Healthcare Systems(GE) Latest Developments
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Information
11.5.2 Illumina, Inc. RNA Analysis And Transcriptomics Product Offered
11.5.3 Illumina, Inc. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Illumina, Inc. Main Business Overview
11.5.5 Illumina, Inc. Latest Developments
11.6 Qiagen N.V.
11.6.1 Qiagen N.V. Company Information
11.6.2 Qiagen N.V. RNA Analysis And Transcriptomics Product Offered
11.6.3 Qiagen N.V. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Qiagen N.V. Main Business Overview
11.6.5 Qiagen N.V. Latest Developments
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Information
11.7.2 F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Product Offered
11.7.3 F. Hoffmann-La Roche Ltd. RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.7.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.8 Sigma-Aldrich(Merck KGaA)
11.8.1 Sigma-Aldrich(Merck KGaA) Company Information
11.8.2 Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Product Offered
11.8.3 Sigma-Aldrich(Merck KGaA) RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sigma-Aldrich(Merck KGaA) Main Business Overview
11.8.5 Sigma-Aldrich(Merck KGaA) Latest Developments
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Information
11.9.2 Fluidigm Corporation RNA Analysis And Transcriptomics Product Offered
11.9.3 Fluidigm Corporation RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Fluidigm Corporation Main Business Overview
11.9.5 Fluidigm Corporation Latest Developments
11.10 Danaher Corporation
11.10.1 Danaher Corporation Company Information
11.10.2 Danaher Corporation RNA Analysis And Transcriptomics Product Offered
11.10.3 Danaher Corporation RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Danaher Corporation Main Business Overview
11.10.5 Danaher Corporation Latest Developments
11.11 Acobiom
11.11.1 Acobiom Company Information
11.11.2 Acobiom RNA Analysis And Transcriptomics Product Offered
11.11.3 Acobiom RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Acobiom Main Business Overview
11.11.5 Acobiom Latest Developments
11.12 Lexogen GmbH
11.12.1 Lexogen GmbH Company Information
11.12.2 Lexogen GmbH RNA Analysis And Transcriptomics Product Offered
11.12.3 Lexogen GmbH RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Lexogen GmbH Main Business Overview
11.12.5 Lexogen GmbH Latest Developments
11.13 Promega Corporation
11.13.1 Promega Corporation Company Information
11.13.2 Promega Corporation RNA Analysis And Transcriptomics Product Offered
11.13.3 Promega Corporation RNA Analysis And Transcriptomics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Promega Corporation Main Business Overview
11.13.5 Promega Corporation Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂